[Pe-02] English Poster Session 02
Dementia (biomarker, test method 2)

[Pe-02-9] Results of thirty-six-month amyloid PET: continuous reduction in amyloid burden with gantenerumab

^○Gregory Klein¹, Paul Delmar², Geoffrey A. Kerchner², Carsten Hofmann², Danielle Abi-saab², Smiljana Ristic³, Andrew Davis³, Nicola Voyle³, Hironori Tatsuda⁴, Monika Baudler², Paulo Fontoura², Rachelle Doody⁵ (1.Roche Pharma Research and Early Development, Switzerland, 2.Roche/Genentech Product Development, 3.Roche Products Ltd., 4.Chugai Pharmaceutical Co., Ltd., 5.Genentech, Inc.)